Exosomes, known as nanometer‐sized vesicles (30–200 nm), are secreted by many types of
cells. Cancer‐derived exosomes have great potential to be biomarkers for early clinical …

Exosomes (exos) widely existing in body fluids show great potential for noninvasive cancer
diagnosis. Quantitative analysis of exos is traditionally performed by targeting specific …

Exosomes, which can transfer and deliver information about the original cell, are considered
to be ideal candidates for early cancer diagnosis and evaluation of therapeutic efficacy due …

Exosomes have emerged as potential biomarkers for pancreatic cancer (PaC). However, it is
still challenging to get quantitative detection of exosomes with the specific surface receptors …

Surface-enhanced Raman scattering (SERS) has received significant attention for analytical
and diagnostic applications in cancer research due to its potency for detecting low …

Extracellular vesicles (EVs), including exosomes, are promising circulating biomarkers for
disease diagnosis. Conventional EVs analysis requires multiple instrumentations to obtain …

Exosomes are promising new biomarkers for colorectal cancer (CRC) diagnosis, due to their
rich biological fingerprints and high level of stability. However, the accurate detection of …

The tissue inhibitor of metalloproteinases-1 (TIMP-1) protein can regulate the expression of
certain proteases and microRNAs in cancer cells, and it is highly possible to diagnose …

Exosomes are potential and promising natural noninvasive biomarkers for liquid biopsies
and can be involved in various biological and pathological processes in early-stage cancer …

Protein profiles of exosomes (EXOs) in clinical samples of cancer patients have become a
promising diagnostic and therapeutic biomarker. However, simultaneous quantitative …